| Pacific Fertility Center Los Angeles (PFCLA) | 80.0 | 3 | 3 |
| Texas Fertility Center | 71.7 | 3 | 2 |
| Prelude Fertility | 71.7 | 3 | 2 |
| EurekAlert! | 60.0 | 7 | 0 |
| Pacific Fertility Center | 60.0 | 3 | 1 |
| Midwest Fertility Specialists | 51.7 | 2 | 1 |
| San Diego Fertility Center | 51.7 | 2 | 1 |
| Shady Grove Fertility Center | 51.7 | 2 | 1 |
| Fertility Centers of Illinois | 51.7 | 2 | 1 |
| New Hope Fertility Center | 51.7 | 2 | 1 |
| Mayo Clinic | 46.4 | 4 | 0 |
| National Institute for Occupational Safety and Health | 40.0 | 3 | 0 |
| Q229883 | 40.0 | 3 | 0 |
| fertility clinic | 40.0 | 0 | 3 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 40.0 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 40.0 | 3 | 0 |
| Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer | 40.0 | 0 | 3 |
| Office of Readiness and Response | 40.0 | 3 | 0 |
| A 5-year analysis of demographics, cycle characteristics and reproductive outcomes of 907 egg freezing cycles in patients with diminished ovarian reserve and age-related fertility decline | 40.0 | 0 | 3 |
| Anti-mullerian hormone level as a predictor of ovarian reserve in patients seeking fertility preservation versus infertility treatment | 40.0 | 0 | 3 |
| Prognostic data in fertility preservation: the role of preimplantation genetic testing for aneuploidy (PGT-A) among cancer patients undergoing embryo banking (EB) | 40.0 | 0 | 3 |
| Clinical trial NCT07597382 | 40.0 | 3 | 0 |
| Clinical trial NCT07585825 | 40.0 | 3 | 0 |
| Clinical trial NCT07571616 | 40.0 | 3 | 0 |
| Clinical trial NCT07571629 | 40.0 | 3 | 0 |
| Clinical trial NCT07611032 | 40.0 | 3 | 0 |
| assisted reproductive technology | 31.7 | 0 | 2 |
| Massachusetts General Hospital | 31.7 | 2 | 0 |
| Nucleic Acids Research | 31.7 | 2 | 0 |
| Newsweek | 31.7 | 2 | 0 |
| Epi Info | 31.7 | 2 | 0 |
| Cleveland Clinic | 31.7 | 2 | 0 |
| American Journal of Translational Research | 31.7 | 2 | 0 |
| Biomedical Optics Express | 31.7 | 2 | 0 |
| ClinicalTrials.gov | 31.7 | 2 | 0 |
| dbSNP | 31.7 | 2 | 0 |
| Preventing Chronic Disease | 31.7 | 2 | 0 |
| Western Journal of Medicine | 31.7 | 2 | 0 |
| Trends in Amplification | 31.7 | 2 | 0 |
| Ulster Medical Journal | 31.7 | 2 | 0 |
| The AAPS Journal | 31.7 | 2 | 0 |
| Rice | 31.7 | 2 | 0 |
| AAPS PharmSciTech | 31.7 | 2 | 0 |
| International Journal of Mental Health Systems | 31.7 | 2 | 0 |
| Journal of Urban Health | 31.7 | 2 | 0 |
| Neural Development | 31.7 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 31.7 | 2 | 0 |
| National Survey of Family Growth | 31.7 | 2 | 0 |
| National Vital Statistics System | 31.7 | 2 | 0 |
| NIOSH Power Tools Database | 31.7 | 2 | 0 |
| UCLA Health System | 31.7 | 2 | 0 |
| Q20641742 | 31.7 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 31.7 | 2 | 0 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 31.7 | 0 | 2 |
| The Journal of clinical and aesthetic dermatology | 31.7 | 2 | 0 |
| Alcohol research : current reviews | 31.7 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 31.7 | 2 | 0 |
| Dermato-endocrinology | 31.7 | 2 | 0 |
| British Heart Journal | 31.7 | 2 | 0 |
| The western journal of emergency medicine | 31.7 | 2 | 0 |
| Psychiatry | 31.7 | 2 | 0 |
| Mycobiology | 31.7 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 31.7 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 31.7 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 31.7 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 31.7 | 2 | 0 |
| NCHS data brief | 31.7 | 2 | 0 |
| MMWR supplements | 31.7 | 2 | 0 |
| Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents | 31.7 | 0 | 2 |
| National Center for Emerging and Zoonotic Infectious Diseases | 31.7 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 31.7 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 31.7 | 2 | 0 |
| Colorado Center for Reproductive Medicine | 31.7 | 2 | 0 |
| Fertility clinic, egg donation agency, and sperm bank policies | 31.7 | 0 | 2 |
| Live birth in a 46 year old using autologous oocytes cryopreserved for a duration of 3 years: a case report documenting fertility preservation at an advanced reproductive age | 31.7 | 0 | 2 |
| Antral follicle count in normal (fertility-proven) and infertile Indian women | 31.7 | 0 | 2 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 31.7 | 0 | 2 |
| RETIRED: Advanced Reproductive Age and Fertility | 31.7 | 0 | 2 |
| Maternal age and initial β-hCG levels predict pregnancy outcome after single vitrified-warmed blastocyst transfer | 31.7 | 0 | 2 |
| Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH | 31.7 | 0 | 2 |
| Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. | 31.7 | 0 | 2 |
| The utility of embryo banking in order to increase the number of embryos available for preimplantation genetic screening in advanced maternal age patients | 31.7 | 0 | 2 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 31.7 | 0 | 2 |
| When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials | 31.7 | 0 | 2 |
| Deep intrauterine insemination and embryo transfer in pigs. | 31.7 | 0 | 2 |
| Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve | 31.7 | 0 | 2 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 31.7 | 0 | 2 |
| Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. | 31.7 | 0 | 2 |
| Trophectoderm morphology predicts outcomes of pregnancy in vitrified-warmed single-blastocyst transfer cycle in a Chinese population | 31.7 | 0 | 2 |
| Donor egg IVF model to assess ecological implications for ART success | 31.7 | 0 | 2 |
| Evidence to Incorporate Inclusive Reproductive Health Measures in Guidelines for Childhood and Adolescent Cancer Survivors | 31.7 | 0 | 2 |
| A legal-ethical analysis of reproductive endocrinologists' right to refuse ovulation induction to patients with diminished ovarian reserve | 31.7 | 0 | 2 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 31.7 | 0 | 2 |
| Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics | 31.7 | 0 | 2 |
| Optimal timing for elective egg freezing | 31.7 | 0 | 2 |
| Single vitrified blastocyst transfer maximizes liveborn children per embryo while minimizing preterm birth | 31.7 | 0 | 2 |
| Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function | 31.7 | 0 | 2 |
| Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe? | 31.7 | 0 | 2 |
| Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study | 31.7 | 0 | 2 |
| Use of anti-mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwide | 31.7 | 0 | 2 |
| Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey | 31.7 | 0 | 2 |
| The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program | 31.7 | 0 | 2 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 31.7 | 0 | 2 |
| Elective single-embryo transfer improves cumulative pregnancy outcome in young patients but not in women of advanced reproductive age | 31.7 | 0 | 2 |
| Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination | 31.7 | 0 | 2 |
| Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging | 31.7 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 31.7 | 0 | 2 |
| The role of fertility preservation in patients with endometriosis | 31.7 | 0 | 2 |
| Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve | 31.7 | 0 | 2 |
| Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies | 31.7 | 0 | 2 |
| Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (eSET): a national study | 31.7 | 0 | 2 |
| Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies | 31.7 | 0 | 2 |
| The correlation of the antral follicle count and Serum anti-mullerian hormone | 31.7 | 0 | 2 |
| Day 3 ET, single blastocyst transfer (SBT) or frozen-thawed embryo transfer (FET): which is preferable for high responder patients in IVF/ICSI cycles? | 31.7 | 0 | 2 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 31.7 | 0 | 2 |
| Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study | 31.7 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 31.7 | 0 | 2 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 31.7 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 31.7 | 0 | 2 |
| Multiple gestations/pregnancies from IVF process in a fertility center in Nigeria, 2009-2011: implementing policy towards fewer (double and single) embryo transfer | 31.7 | 0 | 2 |
| Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? | 31.7 | 0 | 2 |
| Ovarian stem cells—Potential roles in infertility treatment and fertility preservation | 31.7 | 0 | 2 |
| Comprehensive chromosome screening of trophectoderm with vitrification facilitates elective single-embryo transfer for infertile women with advanced maternal age. | 31.7 | 0 | 2 |
| Freezing the biological clock: a viable fertility preservation option for young Singapore women? | 31.7 | 0 | 2 |
| The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. | 31.7 | 0 | 2 |
| Fertility preservation for age-related fertility decline | 31.7 | 0 | 2 |
| Shifting Paradigms in Diminished Ovarian Reserve and Advanced Reproductive Age in Assisted Reproduction: Customization Instead of Conformity | 31.7 | 0 | 2 |
| Fertility Preservation in Women with Ovarian Endometriosis | 31.7 | 0 | 2 |
| Molecular aspects and clinical methods for preserving ovarian reserves in women receiving cancer treatment | 31.7 | 0 | 2 |
| What women want? A scoping survey on women's knowledge, attitudes and behaviours towards ovarian reserve testing and egg freezing. | 31.7 | 0 | 2 |
| Urinary triclosan concentrations and diminished ovarian reserve among women undergoing treatment in a fertility clinic | 31.7 | 0 | 2 |
| Lesbian, gay, bisexual, transgender content on reproductive endocrinology and infertility clinic websites | 31.7 | 0 | 2 |
| Infertility in advanced reproductive age. Results of in vitro fertilization and embryo transfer according to the woman's age. | 31.7 | 0 | 2 |
| Assessment of ovarian reserve and fertility preservation strategies in children treated for cancer. | 31.7 | 0 | 2 |
| Increasing awareness of age-related fertility and elective fertility preservation among medical students and house staff: a pre- and post-intervention analysis | 31.7 | 0 | 2 |
| Euploidy rates in donor egg cycles significantly differ between fertility centers | 31.7 | 0 | 2 |
| Embryo transfer simulation improves pregnancy rates and decreases time to proficiency in Reproductive Endocrinology and Infertility fellow embryo transfers | 31.7 | 0 | 2 |
| Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey | 31.7 | 0 | 2 |
| Effect of smoking on ovarian reserve and ovarian stimulation in in- vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome. | 31.7 | 0 | 2 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 31.7 | 0 | 2 |
| Egg freezing for age-related fertility decline: preventive medicine or a further medicalization of reproduction? Analyzing the new Israeli policy | 31.7 | 0 | 2 |
| Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing | 31.7 | 0 | 2 |
| Assessment of ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with familial Mediterranean fever | 31.7 | 0 | 2 |
| Women's intentions to use fertility preservation to prevent age-related fertility decline | 31.7 | 0 | 2 |
| Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization–Embryo Transfer Outcomes | 31.7 | 0 | 2 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 31.7 | 0 | 2 |
| Infertility treatment in women over 40 years of age | 31.7 | 0 | 2 |
| Egg donation of vitrified oocytes bank produces similar pregnancy rates by blastocyst transfer when compared to fresh cycle | 31.7 | 0 | 2 |
| The Russian experience of autotransplantation of vitrified ovarian tissue to a cancer patient | 31.7 | 0 | 2 |
| Women's age and embryo developmental speed accurately predict clinical pregnancy after single vitrified-warmed blastocyst transfer | 31.7 | 0 | 2 |
| Outcomes of blastocysts biopsied and vitrified once versus those cryopreserved twice for euploid blastocyst transfer | 31.7 | 0 | 2 |
| Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles--time for a new embryo transfer strategy? | 31.7 | 0 | 2 |
| Lapse in embryo transfer training does not negatively affect clinical pregnancy rates for reproductive endocrinology and infertility fellows | 31.7 | 0 | 2 |
| Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations | 31.7 | 0 | 2 |
| Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. | 31.7 | 0 | 2 |
| Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment | 31.7 | 0 | 2 |
| IVF Treatment and Single Embryo Transfer | 31.7 | 0 | 2 |
| More women over 40 seek fertility treatment | 31.7 | 0 | 2 |
| Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility | 31.7 | 0 | 2 |
| Usage of herbal medications in patients undergoing IVF treatment in an Irish infertility treatment unit | 31.7 | 0 | 2 |
| Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist | 31.7 | 0 | 2 |
| Comparison of the offspring sex ratio between cleavage stage embryo transfer and blastocyst transfer | 31.7 | 0 | 2 |
| Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations | 31.7 | 0 | 2 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment | 31.7 | 0 | 2 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 31.7 | 0 | 2 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 31.7 | 0 | 2 |
| Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial | 31.7 | 0 | 2 |
| Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment | 31.7 | 0 | 2 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 31.7 | 0 | 2 |
| Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy | 31.7 | 0 | 2 |
| The Impact of Adnexal Torsion on Antral Follicle Count when Compared With Contralateral Ovary | 31.7 | 0 | 2 |
| Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan | 31.7 | 0 | 2 |
| Intrauterine insemination of cultured peripheral blood mononuclear cells prior to embryo transfer improves clinical outcome for patients with repeated implantation failures | 31.7 | 0 | 2 |
| Does very advanced maternal age, with or without egg donation, really increase obstetric risk in a large tertiary center? | 31.7 | 0 | 2 |
| Evolution of a reproductive endocrinologist: the Society for Reproductive Endocrinology and Infertility fellows retreat and preliminary results of manpower survey | 31.7 | 0 | 2 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 31.7 | 0 | 2 |
| Frozen-thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan | 31.7 | 0 | 2 |
| Factors associated with dizygotic twinning after IVF treatment with double embryo transfer | 31.7 | 0 | 2 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 31.7 | 0 | 2 |
| Role of antral follicle count in controlled ovarian hyperstimulation and intrauterine insemination cycles in patients with unexplained subfertility | 31.7 | 0 | 2 |
| Medical egg freezing: the importance of a patient-centered approach to fertility preservation | 31.7 | 0 | 2 |
| Medical egg freezing and cancer patients' hopes: Fertility preservation at the intersection of life and death | 31.7 | 0 | 2 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 31.7 | 0 | 2 |
| Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients | 31.7 | 0 | 2 |
| Egg Freezing for Age-Related Fertility Decline | 31.7 | 0 | 2 |
| The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model | 31.7 | 0 | 2 |
| Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles | 31.7 | 0 | 2 |
| Mitochondrial SIRT5 is present in follicular cells and is altered by reduced ovarian reserve and advanced maternal age | 31.7 | 0 | 2 |
| Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization | 31.7 | 0 | 2 |
| First line fertility treatment strategies regarding IUI and IVF require clinical evidence | 31.7 | 0 | 2 |
| Reproductive Ethics in Commercial Surrogacy: Decision-Making in IVF Clinics in New Delhi, India | 31.7 | 0 | 2 |
| Assessment of ovarian reserve by antral follicle count in ovaries with endometrioma | 31.7 | 0 | 2 |
| Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? | 31.7 | 0 | 2 |
| Elective single blastocyst transfer in advanced maternal age. | 31.7 | 0 | 2 |
| Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer | 31.7 | 0 | 2 |
| BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles | 31.7 | 0 | 2 |
| Live birth in a 50-year-old woman following in vitro fertilization–embryo transfer with autologous oocytes: a rare case report | 31.7 | 0 | 2 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 31.7 | 0 | 2 |
| Mitochondrial SIRT3 and its target glutamate dehydrogenase are altered in follicular cells of women with reduced ovarian reserve or advanced maternal age | 31.7 | 0 | 2 |
| Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count | 31.7 | 0 | 2 |
| Women with reduced ovarian reserve or advanced maternal age have an altered follicular environment | 31.7 | 0 | 2 |
| Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure | 31.7 | 0 | 2 |
| A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer | 31.7 | 0 | 2 |
| The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study | 31.7 | 0 | 2 |
| Treating women under 36 years old without top-quality embryos on day 2: a prospective study comparing double embryo transfer with single blastocyst transfer | 31.7 | 0 | 2 |
| Improved pregnancy outcome for women with decreased ovarian oocyte reserve and advanced reproductive age by performing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Prediction of ovarian reserve based on day-3 serum follicle stimulating hormone concentrations during the pituitary suppression cycle using a gonadotropin releasing hormone agonist in patients undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer | 31.7 | 0 | 2 |
| Infertility treatment in women over 40 years of age. | 31.7 | 0 | 2 |
| Blastocyst transfer in day-5 embryo transfer depends primarily on the number of oocytes retrieved and not on age | 31.7 | 0 | 2 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 31.7 | 0 | 2 |
| Achieving multiple-order embryo transfer identifies women over 40 years of age with improved in vitro fertilization outcome | 31.7 | 0 | 2 |
| Egg donation to women over 40 years of age. | 31.7 | 0 | 2 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 31.7 | 0 | 2 |
| Johns Hopkins Medicine | 31.7 | 2 | 0 |
| Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers | 31.7 | 0 | 2 |
| Rethinking the biological clock: eleventh-hour moms, miracle moms and meanings of age-related infertility | 31.7 | 0 | 2 |
| Comparative study of pregnancy outcomes between day 3 embryo transfer and day 5 blastocyst transfer in patients with progesterone elevation | 31.7 | 0 | 2 |
| Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study | 31.7 | 0 | 2 |
| Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship programs. | 31.7 | 0 | 2 |
| Annual report of Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology, 2013 | 31.7 | 0 | 2 |
| Evaluation of Ovarian Reserve Based on Hormonal Parameters, Ovarian Volume, and Antral Follicle Count in Women with Type 2 Diabetes Mellitus | 31.7 | 0 | 2 |
| Cervical cerclage before blastocyst transfer in patients having cryopreserved embryo transfer | 31.7 | 0 | 2 |
| Blastocyst transfer is not associated with increased unfavorable obstetric and perinatal outcomes compared with cleavage-stage embryo transfer | 31.7 | 0 | 2 |
| Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer | 31.7 | 0 | 2 |
| Anti-Müllerian hormone levels after laparoscopic cystectomy for endometriomas as a possible predictor for pregnancy in infertility treatments | 31.7 | 0 | 2 |
| Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer | 31.7 | 0 | 2 |
| Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles | 31.7 | 0 | 2 |
| Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study | 31.7 | 0 | 2 |
| Distributive justice and the regulation of fertility centers: an analysis of the Fertility Clinic Success Rate and Certification Act. | 31.7 | 0 | 2 |
| Pregnancy outcome after blastocyst transfer as compared to early cleavage stage embryo transfer | 31.7 | 0 | 2 |
| Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial | 31.7 | 0 | 2 |
| Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline | 31.7 | 0 | 2 |
| Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type | 31.7 | 0 | 2 |
| Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer | 31.7 | 0 | 2 |
| Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence? | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage | 31.7 | 0 | 2 |
| Fertility preservation for age-related fertility decline | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents | 31.7 | 0 | 2 |
| Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve | 31.7 | 0 | 2 |
| Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved | 31.7 | 0 | 2 |
| Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | 31.7 | 0 | 2 |
| Trigger Time in Advanced Maternal Age Patients With Low AMH | 31.7 | 0 | 2 |
| The Effect of Embryo Culture Under Low Oxygen Tension on Pregnancy Rates | 31.7 | 0 | 2 |
| Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome? | 31.7 | 0 | 2 |
| A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age | 31.7 | 0 | 2 |
| Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics | 31.7 | 0 | 2 |
| Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after Fertilization and Embryo Transfer | 31.7 | 0 | 2 |
| Idealizing Pregnancy Outcome With Single Blastocyst Transfer in a FET Cycle | 31.7 | 0 | 2 |
| Biomarkers of Ovarian Reserve and Correlation With IVF Treatments | 31.7 | 0 | 2 |
| Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve | 31.7 | 0 | 2 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 31.7 | 0 | 2 |
| Embryo Selection by Time Lapse Monitoring for Single Embryo Transfer ("SET") | 31.7 | 0 | 2 |
| Bed Rest or no Bed Rest? | 31.7 | 0 | 2 |
| Anti-Mullerian Hormone (AMH) and Antral Follicle Count as Markers of Ovarian Reserve- Prospective Followup of Young Cancer Patients | 31.7 | 0 | 2 |
| How Dose Coenzyme Q10 Supplementation During Infertility Treatment Effects Pregnancy Outcome | 31.7 | 0 | 2 |
| Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age | 31.7 | 0 | 2 |
| EmbryoGlue as an Embryo Transfer Medium | 31.7 | 0 | 2 |
| Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve | 31.7 | 0 | 2 |
| Embryotransfer Operator and Pregnancy Rate | 31.7 | 0 | 2 |
| Effect of Intrauterine Navigation Using Intrauterine Insemination Catheter for Mock Embryo Transfer Prior to Day 3 Embryo Transfer on Pregnancy Rate: A Pilot Study | 31.7 | 0 | 2 |
| Blastocyst Euploidy Assessment and Conditioned embryO traNsfer | 31.7 | 0 | 2 |
| Effect of Cervical Occlusion During Intrauterine Insemination (IUI) | 31.7 | 0 | 2 |
| Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles | 31.7 | 0 | 2 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 31.7 | 0 | 2 |
| Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound | 31.7 | 0 | 2 |
| Direct intraperitoneal or intrauterine insemination and superovulation in infertility treatment: a randomized study | 31.7 | 0 | 2 |
| Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population | 31.7 | 0 | 2 |
| The value of intrauterine insemination in fertility treatment | 31.7 | 0 | 2 |
| Modified hysterosalpingography catheter for embryo transfer and intrauterine insemination | 31.7 | 0 | 2 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 31.7 | 0 | 2 |
| Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios? | 31.7 | 0 | 2 |
| Gonadotropin and body mass index: high FSH levels in lean, normally cycling women | 31.7 | 0 | 2 |
| BLASTOCYST TRANSFER IN THE MARSUPIAL SETONIX BRACHYURUS | 31.7 | 0 | 2 |
| The Impact of Lifestyle on Sperm Telomere Length and Telomerase Activity in Men Undergoing IVF Treatments | 31.7 | 0 | 2 |
| Infertility treatment and informed consent: current practices of reproductive endocrinologists | 31.7 | 0 | 2 |
| The graduated embryo score predicts the outcome of assisted reproductive technologies better than a single day 3 evaluation and achieves results associated with blastocyst transfer from day 3 embryo transfer | 31.7 | 0 | 2 |
| Pregnancy outcome after blastocyst transfer as compared to early cleavage stage embryo transfer | 31.7 | 0 | 2 |
| Ovarian Reserve and Ankylosing Spondylitis | 31.7 | 0 | 2 |
| Stimulation of endometrium embryo transfer (SEET): injection of embryo culture supernatant into the uterine cavity before blastocyst transfer can improve implantation and pregnancy rates | 31.7 | 0 | 2 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels | 31.7 | 0 | 2 |
| Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? | 31.7 | 0 | 2 |
| Single embryo transfer in IVF treatment | 31.7 | 0 | 2 |
| Antral follicle count in clinical practice: building the bridge from ovarian reserve to in vitro fertilization outcome | 31.7 | 0 | 2 |
| Laparoscopy for intrauterine insemination and embryo recovery in superovulated ewes at a commercial embryo transfer unit | 31.7 | 0 | 2 |
| Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold? | 31.7 | 0 | 2 |
| Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle | 31.7 | 0 | 2 |
| Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti‐Müllerian hormone and small antral follicle count using three‐dimensional ultrasound | 31.7 | 0 | 2 |
| Monozygotic twinning after in vitro fertilization/intracytoplasmic sperm injection treatment is not related to advanced maternal age, intracytoplasmic sperm injection, assisted hatching, or blastocyst transfer | 31.7 | 0 | 2 |
| Reply: Endometrioma excision and ovarian reserve: do assessments by antral follicle count and anti-Müllerian hormone yield contradictory results? | 31.7 | 0 | 2 |
| Endometrioma excision and ovarian reserve; do assessments by antral follicle count and anti-Müllerian hormone yield contradictory results? | 31.7 | 0 | 2 |
| The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne | 31.7 | 0 | 2 |
| Fertility preservation for age-related fertility decline – Authors' reply | 31.7 | 0 | 2 |
| Fertility preservation for age-related fertility decline | 31.7 | 0 | 2 |
| Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages | 31.7 | 0 | 2 |
| Surgery Before Embryo Transfer in ERROR (Endometrioma Related Reduction in Ovarian Reserve) | 31.7 | 0 | 2 |
| Comprehensive chromosome screening with synchronous blastocyst transfer: time for a paradigm shift☆ | 31.7 | 0 | 2 |
| Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers | 31.7 | 0 | 2 |
| Should all embryos be cultured to blastocyst for advanced maternal age women with low ovarian reserve: a single center retrospective study | 31.7 | 0 | 2 |
| Evaluation of ovarian reserve using anti-müllerian hormone and antral follicle count in Sjögren's syndrome: Preliminary study | 31.7 | 0 | 2 |
| The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study | 31.7 | 0 | 2 |
| Elective egg freezing for age-related fertility decline | 31.7 | 0 | 2 |
| Effect of Single-Dose Methotrexate Treatment on Ovarian Reserve in Women with Ectopic Pregnancy Undergoing Infertility Treatment: A Single-Center Experience | 31.7 | 0 | 2 |
| Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study | 31.7 | 0 | 2 |
| Impact of Day 7 Blastocyst Transfer on Obstetric and Perinatal Outcome of Singletons Born After Vitrified-Warmed Embryo Transfer | 31.7 | 0 | 2 |
| Women's attitudes and beliefs about using fertility preservation to prevent age-related fertility decline-A two-year follow-up | 31.7 | 0 | 2 |
| Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial | 31.7 | 0 | 2 |
| Outcomes of in vitro fertilization-embryo transfer in women with diminished ovarian reserve after growth hormone pretreatment | 31.7 | 0 | 2 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 31.7 | 0 | 2 |
| The effects of intrauterine insemination and single embryo transfer or modified natural cycle in vitro fertilization on offspring's health-Follow-up of a randomized clinical trial | 31.7 | 0 | 2 |
| A Comparison of Pregnancy Outcomes in Patients Undergoing Donor Egg Single Embryo Transfers With and Without Preimplantation Genetic Testing | 31.7 | 0 | 2 |
| Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment | 31.7 | 0 | 2 |
| Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate | 31.7 | 0 | 2 |
| Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve | 31.7 | 0 | 2 |
| The ethics of fertility treatment for same-sex male couples: Considerations for a modern fertility clinic | 31.7 | 0 | 2 |
| The Effect of Assisted Hatching on Live Birth Rate Following Fresh Embryo Transfer in Advanced Maternal Age | 31.7 | 0 | 2 |
| Does preimplantation genetic testing for aneuploidy really improve IVF outcomes in advanced maternal age patients without compromising cumulative live-birth rate? | 31.7 | 0 | 2 |
| The effect of a natural vaginal product based on honey on the success of intrauterine insemination (IUI) in infertility treatment | 31.7 | 0 | 2 |
| EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer | 31.7 | 0 | 2 |
| Use of Frozen Embryo Transfer During Fertility Treatment and Risk of Childhood Cancer-Reply | 31.7 | 0 | 2 |
| Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer | 31.7 | 0 | 2 |
| Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): experience of two high-volume fertility clinics | 31.7 | 0 | 2 |
| Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve | 31.7 | 0 | 2 |
| Exposure to Fine Particulate Matter and Ovarian Reserve Among Women from a Fertility Clinic | 31.7 | 0 | 2 |
| Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men's roles in women's fertility preservation | 31.7 | 0 | 2 |
| An economic analysis of preimplantation genetic testing for aneuploidy by polar body biopsy in advanced maternal age | 31.7 | 0 | 2 |
| Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage | 31.7 | 0 | 2 |
| A novel de novo partial xq duplication in a girl with short stature, nonverbal learning disability and diminished ovarian reserve - effect of growth hormone treatment and fertility preservation strategies: a case report and up-to-date review | 31.7 | 0 | 2 |
| Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation | 31.7 | 0 | 2 |
| Live birth rate and neonatal outcome following cleavage-stage embryo transfer versus blastocyst transfer using the freeze-all strategy | 31.7 | 0 | 2 |
| Spontaneous Conception during In Vitro Fertilization prior to Embryo Transfer without the Opportunity for Preimplantation Genetic Testing | 31.7 | 0 | 2 |
| Comparison of the pregnancy and obstetric outcomes between single cleavage-stage embryo transfer and single blastocyst transfer by time-lapse selection of embryos | 31.7 | 0 | 2 |
| Can delivery mode influence future ovarian reserve? Anti-Mullerian hormone levels and antral follicle count following cesarean section: a prospective cohort study | 31.7 | 0 | 2 |
| Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma | 31.7 | 0 | 2 |
| Attitudes and experiences of health care professionals when caring for transgender men undergoing fertility preservation by egg freezing: a qualitative study | 31.7 | 0 | 2 |
| Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve | 31.7 | 0 | 2 |
| The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation | 31.7 | 0 | 2 |
| Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics | 31.7 | 0 | 2 |
| Donor egg is the best second choice for many infertile couples: real progress in overcoming age-related fertility is not here yet | 31.7 | 0 | 2 |
| Dietary patterns and ovarian reserve among women attending a fertility clinic | 31.7 | 0 | 2 |
| Is Preimplantation Genetic Testing Associated with Increased Risk of Abnormal Placentation After Frozen Embryo Transfer? | 31.7 | 0 | 2 |
| The indication for fertility preservation in women with Turner syndrome should not only be based on the ovarian reserve but also on the genotype and expected future health status | 31.7 | 0 | 2 |
| The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women | 31.7 | 0 | 2 |
| Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center | 31.7 | 0 | 2 |
| The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites | 31.7 | 0 | 2 |
| [Impact of sperm DNA fragmentation on the outcome of frozen-thawed blastocyst transfer in in vitro fertilization and embryo transfer] | 31.7 | 0 | 2 |
| Preimplantation Genetic Testing for Aneuploidy of Polar Bodies | 31.7 | 0 | 2 |
| Experiences of women undergoing infertility treatment from embryo transfer until pregnancy test and their conceptualization of their embryo | 31.7 | 0 | 2 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 31.7 | 2 | 0 |
| Stanford Children's Health | 31.7 | 2 | 0 |
| Women’s preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy | 31.7 | 0 | 2 |
| Hysteroscopy With Fundus Uterus Scratching Incision VS Office Hysteroscopy Before ET With Donor Eggs | 31.7 | 0 | 2 |
| Efficacy and Safety of Fertility Treatments and Fertility Preservation | 31.7 | 0 | 2 |
| Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer | 31.7 | 0 | 2 |
| Immediate Versus Postponed Single Blastocyst Transfer in mNC-FET | 31.7 | 0 | 2 |
| Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET | 31.7 | 0 | 2 |
| Healthcare Infection Control Practices Advisory Committee | 31.7 | 2 | 0 |
| P–090 Cumulative live birth rates (CLBR) per embryo transfer, embryo transferred and inseminated oocyte are not affected by paternal age in infertile male donor egg cycles | 31.7 | 0 | 2 |
| Assisted Hatching of the Zona Pellucida Prior to Embryo Transfer in Fresh Donor Egg IVF Cycles | 31.7 | 0 | 2 |
| KINDERWUNSCHZENTRUM LOS ANGELES, INC. | 31.7 | 0 | 2 |
| Progyny, Inc. | 31.7 | 2 | 0 |
| Surgery Before Embryo Transfer in ERROR (Endometrioma Related Reduction in Ovarian Reserve) | 31.7 | 0 | 2 |
| Selecting euploid embryo for transfer by preimplantation genetic testing for aneuploidy improved clinical outcomes in patients with advanced maternal age | 31.7 | 0 | 2 |
| Urinary Triclosan Concentrations and Diminished Ovarian Reserve among Women from a Fertility Clinic | 31.7 | 0 | 2 |
| Blastocyst morphology correlates with preimplantation genetic testing for aneuploidy (PGT-A) results and may further predict pregnancy potential after euploid single embryo transfer (SET) | 31.7 | 0 | 2 |
| Timing of blastocyst development is the sole predictor of positive pregnancy outcome in advanced maternal age patients following single euploid blastocyst transfer | 31.7 | 0 | 2 |
| Does massage therapy immediately prior to embryo transfer improve clinical pregnancy rate in IVF-PGT-A (in-vitro fertilization-preimplantation genetic testing for aneuploidy) cycles? | 31.7 | 0 | 2 |
| Effects of estradiol pretreatment during follicular period on outcome of in vitro fertilization and embryo transfer treatment for poor ovarian responder with high FSH level | 31.7 | 0 | 2 |
| Elective egg freezing and male support: a qualitative study of men’s hidden roles in women’s fertility preservation | 31.7 | 0 | 2 |
| Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a sart-cors study | 31.7 | 0 | 2 |
| Preimplantation genetic testing (PGT) and frozen embryo transfer (FET) synergistically decrease pre-term delivery in patients undergoing in vitro fertilization (IVF) | 31.7 | 0 | 2 |
| 30. LIVE BIRTHS FOLLOWING DAY 7 BLASTOCYST TRANSFER AFTER PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) | 31.7 | 0 | 2 |
| 8. COMPARISON OF NATURAL CYCLES VERSUS HORMONE REPLACEMENT TREATMENT FOR 2398 FROZEN–THAWED EMBRYO TRANSFER CYCLES FOR PREIMPLANTATION GENETIC TESTING PATIENTS | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy: a pragmatic, multicenter randomized clinical trial of single frozen euploid embryo transfer versus selection by morphology alone | 31.7 | 0 | 2 |
| Preimplantation genetic testing for aneuploidy (PGT-A) in donor oocyte single blastocyst transfer cycles: is there benefit? | 31.7 | 0 | 2 |
| Association between the number of oocytes retrieved and cumulative live birth rate in IVF treatment: menopur in GnRH antagonist single embryo transfer - high responder (MEGASET-HR) trial outcomes | 31.7 | 0 | 2 |
| Recent Advances in Reproductive Endocrinology: Implications for Fertility Treatment in Gynecology | 31.7 | 0 | 2 |
| High FSH levels impair VEGF secretion of human, frozen-thawed ovarian cortical tissue in vitro | 31.7 | 0 | 2 |
| Progesterone levels on the day of blastocyst transfer in modified natural cycle frozen embryo transfer cycles: a sub-study of an ongoing randomised controlled trial | 31.7 | 0 | 2 |
| The relevance of antral follicle count (AFC) as a marker of ovarian reserve in normal and infertile women in a tertiary care centre in Central India | 31.7 | 0 | 2 |
| Does embryo biopsy, independent of vitrification, impact perinatal outcomes? An analysis of perinatal outcomes following preimplantation genetic testing biopsy in fresh and frozen embryo transfer cycles | 31.7 | 0 | 2 |
| In vitro Fertilization Treatment Outcomes After Single Blastocyst Transfer in Patients with Markers of Diminished Ovarian Reserve-Does Age Make a Difference? | 31.7 | 0 | 2 |
| Obstetric and Perinatal Outcomes of Pregnancies After Infertility Treatment Using Assisted Reproductive Technologies With Cryopreserved Embryo Transfer | 31.7 | 0 | 2 |
| Egg freezing for fertility preservation and family planning: a survey of OB/GYN residents across united states | 31.7 | 0 | 2 |
| Why looks matter: morphology predicts success in embryo banking (EB) with preimplantation genetic testing for aneuploidy (PGT-A) | 31.7 | 0 | 2 |
| Natural cycle frozen blastocyst transfer after a failed fresh embryo transfer: do we have to wait? | 31.7 | 0 | 2 |
| Is ovarian reserve and reproductive outcome compromised in breast cancer patients? experience in 1000 women undergoing fertility preservation (FP) | 31.7 | 0 | 2 |
| Ovarian reserve tests are associated with the number of oocytes matured in vitro and with the primordial follicle density in a population of candidates for fertility preservation | 31.7 | 0 | 2 |
| Initial serum human chorionic gonadotropin levels predict live birth outcomes following frozen embryo transfer with and without preimplantation genetic testing for aneuploidy (PGT-A) | 31.7 | 0 | 2 |
| Successful live births after Chinese herbal medicine treatment on a patient of advanced maternal age with severe diminished ovarian reserve: A case report | 31.7 | 0 | 2 |
| Preferred strategy for euploid single embryo transfer in advanced maternal age: Fresh versus frozen | 31.7 | 0 | 2 |
| Antral Follicle Count and AMH Level for Ovarian Reserve Comparison | 31.7 | 0 | 2 |
| Single versus double blastocyst transfer in first and second frozen-thawed embryo transfer cycle in advance-aged women: a two-center retrospective cohort study | 31.7 | 0 | 2 |
| The gift of motherhood: Egg donation in a Barcelona infertility clinic | 31.7 | 0 | 2 |
| Cryopreserving Jewish Motherhood: Egg Freezing in Israel and the United States | 31.7 | 0 | 2 |
| Cyprus Fertina IVF Clinic | 31.7 | 0 | 2 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 31.7 | 2 | 0 |
| From scarcity to sisterhood: The framing of egg donation on fertility clinic websites in the UK, Belgium and Spain | 31.7 | 0 | 2 |
| Let ‘Pregnant Women Choose the Destiny for Themselves and Their Child’. How Fertility Clinic Digital Platforms Frame Preimplantation Genetic Testing (PGT) in Spain | 31.7 | 0 | 2 |
| Genesis Fertility Center | 31.7 | 0 | 2 |
| GYN-FIV a.s. | 31.7 | 0 | 2 |
| National Center for Biotechnology Information | 20.0 | 1 | 0 |
| time trouble | 20.0 | 0 | 1 |
| circadian rhythm | 20.0 | 0 | 1 |
| Gigi Fernández | 20.0 | 0 | 1 |
| embryo transfer | 20.0 | 0 | 1 |
| PR Newswire | 20.0 | 1 | 0 |
| American Society for Reproductive Medicine | 20.0 | 1 | 0 |
| HomoloGene | 20.0 | 1 | 0 |
| chronobiology | 20.0 | 0 | 1 |
| United States Centers for Disease Control and Prevention | 20.0 | 1 | 0 |
| Johns Hopkins School of Medicine | 20.0 | 1 | 0 |
| Blood | 20.0 | 1 | 0 |
| GenBank | 20.0 | 1 | 0 |
| egg donation | 20.0 | 0 | 1 |
| Journal of Virology | 20.0 | 1 | 0 |
| Biological clock | 20.0 | 0 | 1 |
| Pennsylvania Hospital | 20.0 | 1 | 0 |
| Entrez | 20.0 | 1 | 0 |
| Johns Hopkins Hospital | 20.0 | 1 | 0 |
| preimplantation genetic diagnosis | 20.0 | 0 | 1 |
| Human Fertilisation and Embryology Authority | 20.0 | 1 | 0 |
| polymyalgia rheumatica | 20.0 | 1 | 0 |
| Morbidity and Mortality Weekly Report | 20.0 | 1 | 0 |
| Nanoscale Research Letters | 20.0 | 1 | 0 |
| Lou Ruvo Center for Brain Health | 20.0 | 1 | 0 |
| eLife | 20.0 | 1 | 0 |
| PeerJ | 20.0 | 1 | 0 |
| Biophysical Journal | 20.0 | 1 | 0 |
| UCLA Ronald Reagan Medical Center | 20.0 | 1 | 0 |
| Journal of Cardiovascular Magnetic Resonance | 20.0 | 1 | 0 |
| Mayo Clinic Hospital — Rochester | 20.0 | 1 | 0 |
| Cancer Biology and Therapy | 20.0 | 1 | 0 |
| Cancer Imaging | 20.0 | 1 | 0 |
| Bioscience Reports | 20.0 | 1 | 0 |
| ACS Chemical Neuroscience | 20.0 | 1 | 0 |
| Acta Histochemica et Cytochemica | 20.0 | 1 | 0 |
| Aging | 20.0 | 1 | 0 |
| Brigham and Women's Hospital | 20.0 | 1 | 0 |
| GeneReviews | 20.0 | 1 | 0 |
| Biomicrofluidics | 20.0 | 1 | 0 |
| Journal of Experimental Medicine | 20.0 | 1 | 0 |
| Satisfaction with Life Index | 20.0 | 1 | 0 |
| Molecular and Cellular Biology | 20.0 | 1 | 0 |
| National Center for Health Statistics | 20.0 | 1 | 0 |
| Vitrification (ovocytes) | 20.0 | 0 | 1 |
| Weill Cornell Medicine | 20.0 | 1 | 0 |
| Eugene Koonin | 20.0 | 1 | 0 |
| biological clock | 20.0 | 0 | 1 |
| advanced maternal age | 20.0 | 0 | 1 |
| Advisory Committee on Immunization Practices | 20.0 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 20.0 | 1 | 0 |
| Anne Schuchat | 20.0 | 1 | 0 |
| BabyCenter | 20.0 | 1 | 0 |
| Canadian Journal of Gastroenterology & Hepatology | 20.0 | 1 | 0 |
| Canadian Respiratory Journal | 20.0 | 1 | 0 |
| Cerebral Cortex | 20.0 | 1 | 0 |
| Cn3D | 20.0 | 1 | 0 |
| Community Memorial Hospital | 20.0 | 1 | 0 |
| Consensus CDS Project | 20.0 | 1 | 0 |
| Conserved Domain Database | 20.0 | 1 | 0 |
| CytoJournal | 20.0 | 1 | 0 |
| Emerging Infectious Diseases | 20.0 | 1 | 0 |
| Diabetes Care | 20.0 | 1 | 0 |
| Endocrinology of reproduction | 20.0 | 0 | 1 |
| Epi Map | 20.0 | 1 | 0 |
| Epidemic Intelligence Service | 20.0 | 1 | 0 |
| Eukaryotic Cell | 20.0 | 1 | 0 |
| European Journal of Medical Research | 20.0 | 1 | 0 |
| Evidence-based Complementary and Alternative Medicine | 20.0 | 1 | 0 |
| fertility preservation | 20.0 | 0 | 1 |
| Fertility testing | 20.0 | 0 | 1 |
| fertility tourism | 20.0 | 0 | 1 |
| Fire Fighter Fatality Investigation and Prevention Program | 20.0 | 1 | 0 |
| Froedtert Hospital | 20.0 | 1 | 0 |
| Genetic codes | 20.0 | 1 | 0 |
| Geriatric orthopaedic surgery & rehabilitation | 20.0 | 1 | 0 |
| Global Health Action | 20.0 | 1 | 0 |
| HSS Journal | 20.0 | 1 | 0 |
| Harborview Medical Center | 20.0 | 1 | 0 |
| Health Hazard Evaluation | 20.0 | 1 | 0 |
| Hospital of the University of Pennsylvania | 20.0 | 1 | 0 |
| Howard County General Hospital | 20.0 | 1 | 0 |
| Human Fertilisation and Embryology (Deceased Fathers) Act 2003 | 20.0 | 0 | 1 |
| IBIS | 20.0 | 1 | 0 |
| Indian Journal of Nephrology | 20.0 | 1 | 0 |
| Indian Journal of Psychological Medicine | 20.0 | 1 | 0 |
| International Journal of Clinical and Experimental Medicine | 20.0 | 1 | 0 |
| International Journal of Clinical and Experimental Pathology | 20.0 | 1 | 0 |
| Jeff Stein | 20.0 | 1 | 0 |
| Journal of Cutaneous and Aesthetic Surgery | 20.0 | 1 | 0 |
| Journal of Medical Ethics | 20.0 | 1 | 0 |
| Journal of the Experimental Analysis of Behavior | 20.0 | 1 | 0 |
| Journal of the International AIDS Society | 20.0 | 1 | 0 |
| UCLA Jules Stein Eye Institute | 20.0 | 1 | 0 |
| Lucile Packard Children's Hospital | 20.0 | 1 | 0 |
| Mayo Clinic Hospital – Jacksonville | 20.0 | 1 | 0 |
| McGill Journal of Medicine | 20.0 | 1 | 0 |
| Milbank Quarterly | 20.0 | 1 | 0 |
| Mindkiller | 20.0 | 0 | 1 |
| Molecular Medicine | 20.0 | 1 | 0 |
| NYU Langone Health | 20.0 | 1 | 0 |
| Black Women’s Health Imperative | 20.0 | 1 | 0 |
| National Center for Injury Prevention and Control | 20.0 | 1 | 0 |
| National Diabetes Education Program | 20.0 | 1 | 0 |
| National Health Interview Survey | 20.0 | 1 | 0 |
| Northwest Hospital & Medical Center | 20.0 | 1 | 0 |
| ovarian reserve | 20.0 | 0 | 1 |
| Penn Presbyterian Medical Center | 20.0 | 1 | 0 |
| Perelman Center for Advanced Medicine | 20.0 | 1 | 0 |
| poor ovarian reserve | 20.0 | 0 | 1 |
| Psychological Reports | 20.0 | 1 | 0 |
| Public Health Information Network | 20.0 | 1 | 0 |
| RefSeq | 20.0 | 1 | 0 |
| Reproductive endocrinology | 20.0 | 0 | 1 |
| Scheie Eye Institute | 20.0 | 1 | 0 |
| semen collection | 20.0 | 0 | 1 |
| Sexually Transmitted Infections | 20.0 | 1 | 0 |
| Sibley Memorial Hospital | 20.0 | 1 | 0 |
| Slovenian fertility treatment referendum, 2001 | 20.0 | 0 | 1 |
| Stanford Hospital and Clinics | 20.0 | 1 | 0 |
| Stanford University Medical Center | 20.0 | 1 | 0 |
| The Journal of Chiropractic Education | 20.0 | 1 | 0 |
| Time Pressure | 20.0 | 0 | 1 |
| Time pressure gauge | 20.0 | 0 | 1 |
| UCLA Santa Monica Medical Center | 20.0 | 1 | 0 |
| UCSF Medical Center | 20.0 | 1 | 0 |
| UniGene | 20.0 | 1 | 0 |
| Univec | 20.0 | 1 | 0 |
| University of Chicago Comprehensive Cancer Center | 20.0 | 1 | 0 |
| UChicago Medicine | 20.0 | 1 | 0 |
| University of Pennsylvania Health System | 20.0 | 1 | 0 |
| University of Washington Medical Center | 20.0 | 1 | 0 |
| University of Washington School of Medicine | 20.0 | 1 | 0 |
| VERB | 20.0 | 1 | 0 |
| Vaccines for Children Program | 20.0 | 1 | 0 |
| Victor Velculescu | 20.0 | 1 | 0 |
| WWAMI Regional Medical Education Program | 20.0 | 1 | 0 |
| NIOSH World Trade Center Health Program | 20.0 | 1 | 0 |
| Taxonomy database of the U.S. National Center for Biotechnology Information | 20.0 | 1 | 0 |
| Sidra Medical and Research Center | 20.0 | 1 | 0 |
| Q12306678 | 20.0 | 0 | 1 |
| intrauterine insemination | 20.0 | 0 | 1 |
| Stem Cell Research & Therapy | 20.0 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 20.0 | 1 | 0 |
| Theodore H. Schwartz | 20.0 | 1 | 0 |
| MMDB | 20.0 | 1 | 0 |
| Tissue Barriers | 20.0 | 1 | 0 |
| Small GTPases (journal) | 20.0 | 1 | 0 |
| The Eugenics Review | 20.0 | 1 | 0 |
| Translational Psychiatry | 20.0 | 1 | 0 |
| Molecular Autism | 20.0 | 1 | 0 |
| Physiological Reports | 20.0 | 1 | 0 |
| Physiotherapy Canada | 20.0 | 1 | 0 |
| Clinical and Developmental Immunology | 20.0 | 1 | 0 |
| Journal of Nematology | 20.0 | 1 | 0 |
| Journal of Physiological Anthropology | 20.0 | 1 | 0 |
| The Behavior Analyst | 20.0 | 1 | 0 |
| Advances in Pharmacological Sciences | 20.0 | 1 | 0 |
| Medical Science Monitor | 20.0 | 1 | 0 |
| The World Allergy Organization Journal | 20.0 | 1 | 0 |
| Integrative Medicine | 20.0 | 1 | 0 |
| Addiction Science and Clinical Practice | 20.0 | 1 | 0 |
| Journal of Human Virology | 20.0 | 1 | 0 |
| Molecular Cytogenetics | 20.0 | 1 | 0 |
| Organogenesis | 20.0 | 1 | 0 |
| Clinical Diabetes | 20.0 | 1 | 0 |
| Journal of the American Association for Laboratory Animals | 20.0 | 1 | 0 |
| Journal of Children's Orthopaedics | 20.0 | 1 | 0 |
| Learning and Memory | 20.0 | 1 | 0 |
| Environmental Health Insights | 20.0 | 1 | 0 |
| Tobacco Control | 20.0 | 1 | 0 |
| American Journal of Tropical Medicine and Hygiene | 20.0 | 1 | 0 |
| Genome Integrity | 20.0 | 1 | 0 |
| Mobile DNA | 20.0 | 1 | 0 |
| Silence: a journal of RNA regulation | 20.0 | 1 | 0 |
| mBio | 20.0 | 1 | 0 |
| Journal of Laboratory Physicians | 20.0 | 1 | 0 |
| Surgical Neurology International | 20.0 | 1 | 0 |
| Journal of Clinical Imaging Science | 20.0 | 1 | 0 |
| Fluids and Barriers of the CNS | 20.0 | 1 | 0 |
| Akanksha Infertility Clinic | 20.0 | 0 | 1 |
| epigenetic clock | 20.0 | 0 | 1 |
| National Death Index | 20.0 | 1 | 0 |
| National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention | 20.0 | 1 | 0 |
| Suburban Hospital | 20.0 | 1 | 0 |
| National Center for Immunization and Respiratory Diseases | 20.0 | 1 | 0 |
| reproductive endocrinology and infertility | 20.0 | 0 | 1 |
| Gene Expression Omnibus | 20.0 | 1 | 0 |
| American Journal of Cancer Research | 20.0 | 1 | 0 |
| haste | 20.0 | 0 | 1 |
| NCBI Homo sapiens Annotation Release 106 | 20.0 | 1 | 0 |
| OncoImmunology | 20.0 | 1 | 0 |
| NCBI Mus musculus Annotation Release 104 | 20.0 | 1 | 0 |
| Airlift Northwest | 20.0 | 1 | 0 |
| International Archives of Medicine | 20.0 | 1 | 0 |
| Q19295255 | 20.0 | 1 | 0 |
| NCBI Acyrthosiphon pisum Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Ailuropoda melanoleuca Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Alligator mississippiensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Anolis carolinensis Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Apaloderma vittatum Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Apis dorsata Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Apis mellifera Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Aptenodytes forsteri Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Astyanax mexicanus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Bactrocera cucurbitae Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Bactrocera dorsalis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Balaenoptera acutorostrata scammoni Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Balearica regulorum gibbericeps Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Beta vulgaris subsp. vulgaris Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Bison bison bison Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Bos taurus Annotation Release 104 | 20.0 | 1 | 0 |
| NCBI Brachypodium distachyon Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Brassica rapa Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Buceros rhinoceros silvestris Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Callithrix jacchus Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Callorhinchus milii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Calypte anna Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Camelina sativa Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Camelus bactrianus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Camelus dromedarius Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Camelus ferus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Camponotus floridanus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Caprimulgus carolinensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Cariama cristata Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Chaetura pelagica Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Charadrius vociferus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Chelonia mydas Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Chlamydotis macqueenii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Chlorocebus sabaeus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Chrysemys picta Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Chrysochloris asiatica Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Ciona intestinalis Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Citrus sinensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Colius striatus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Corvus brachyrhynchos Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Corvus cornix cornix Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Cricetulus griseus Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Cuculus canorus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Cucumis melo Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Cynoglossus semilaevis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Danio rerio Annotation Release 104 | 20.0 | 1 | 0 |
| NCBI Egretta garzetta Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Elaeis guineensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Elephantulus edwardii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Eptesicus fuscus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Equus przewalskii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Erinaceus europaeus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Esox lucius Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Eucalyptus grandis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Eurypyga helias Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Felis catus Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Felis catus Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Fopius arisanus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Fukomys damarensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Fulmarus glacialis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Gavia stellata Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Glycine max Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Haliaeetus albicilla Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Haliaeetus leucocephalus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Harpegnathos saltator Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Larimichthys crocea Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Lepisosteus oculatus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Leptonychotes weddellii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Leptosomus discolor Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Lipotes vexillifer Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Loxodonta africana Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Malus domestica Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Manacus vitellinus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Meleagris gallopavo Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Merops nubicus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Mesitornis unicolor Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Microplitis demolitor Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Monodelphis domestica Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Musa acuminata Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Musca domestica Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Myotis davidii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nannospalax galili Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nasonia vitripennis Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Nelumbo nucifera Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Neolamprologus brichardi Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nestor notabilis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nicotiana sylvestris Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nicotiana tomentosiformis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Nipponia nippon Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Notothenia coriiceps Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Opisthocomus hoazin Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Ornithorhynchus anatinus Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Orycteropus afer afer Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Oryctolagus cuniculus Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Oryza brachyantha Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pan paniscus Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Pan troglodytes Annotation Release 103 | 20.0 | 1 | 0 |
| NCBI Panthera tigris altaica Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Papio anubis Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Pelecanus crispus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Peromyscus maniculatus bairdii Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Phaethon lepturus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Phalacrocorax carbo Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Phoenix dactylifera Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Physeter catodon Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Picoides pubescens Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Poecilia formosa Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Poecilia reticulata Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pongo abelii Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Populus euphratica Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Prunus mume Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pterocles gutturalis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pteropus alecto Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pygoscelis adeliae Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Pyrus x bretschneideri Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Python bivittatus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Rattus norvegicus Annotation Release 104 | 20.0 | 1 | 0 |
| NCBI Rattus norvegicus Annotation Release 105 | 20.0 | 1 | 0 |
| NCBI Rhinopithecus roxellana Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Saccoglossus kowalevskii Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Saimiri boliviensis Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Serinus canaria Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Sesamum indicum Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Solanum lycopersicum Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Solanum tuberosum Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Solenopsis invicta Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Stegastes partitus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Struthio camelus australis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tarenaya hassleriana Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tarsius syrichta Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tauraco erythrolophus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tinamus guttatus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tribolium castaneum Annotation Release 102 | 20.0 | 1 | 0 |
| NCBI Tupaia chinensis Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Tyto alba Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Ursus maritimus Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Vicugna pacos Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Vitis vinifera Annotation Release 101 | 20.0 | 1 | 0 |
| NCBI Zea mays Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Acromyrmex echinatior Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Acanthisitta chloris Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Galeopterus variegatus Annotation Release 100 | 20.0 | 1 | 0 |
| database of Genotypes and Phenotypes | 20.0 | 1 | 0 |
| Edward Thomas Ryan | 20.0 | 1 | 0 |
| Interventional Neuroradiology | 20.0 | 1 | 0 |
| Identifying sigma factors in Mycobacterium smegmatis by comparative genomic analysis | 20.0 | 1 | 0 |
| Zhiyong Lu | 20.0 | 1 | 0 |
| Crowdsourcing in biomedicine: challenges and opportunities | 20.0 | 1 | 0 |
| NM 000492.3(CFTR):c.1521 1523delCTT (p.Phe508delPhe) | 20.0 | 1 | 0 |
| NIOSH pocket guide to chemical hazards (superseded) | 20.0 | 1 | 0 |
| ClinVar | 20.0 | 1 | 0 |
| ASN Neuro | 20.0 | 1 | 0 |
| Aging and Disease | 20.0 | 1 | 0 |
| Brain and Behavior | 20.0 | 1 | 0 |
| NCBI Bacterial Annotation Release 70 | 20.0 | 1 | 0 |
| Advances in Nutrition | 20.0 | 1 | 0 |
| NCBI homo sapiens annotation release 107 | 20.0 | 1 | 0 |
| genome assembly GRCh38 | 20.0 | 1 | 0 |
| NCBI mus musculus annotation release 105 | 20.0 | 1 | 0 |
| Genome assembly GRCm38.p3 | 20.0 | 1 | 0 |
| HomoloGene build68 | 20.0 | 1 | 0 |
| Cold Spring Harbor Perspectives in Medicine | 20.0 | 1 | 0 |
| Genome assembly GRCh37 | 20.0 | 1 | 0 |
| Human ovarian reserve from conception to the menopause | 20.0 | 0 | 1 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 20.0 | 0 | 1 |
| From biological clock to biological rhythms | 20.0 | 0 | 1 |
| Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study | 20.0 | 0 | 1 |
| Amphibian & Reptile Conservation | 20.0 | 1 | 0 |
| William G. Nelson | 20.0 | 1 | 0 |
| Consensus on infertility treatment related to polycystic ovary syndrome | 20.0 | 0 | 1 |
| An historical look at embryo transfer | 20.0 | 0 | 1 |
| Source Code for Biology and Medicine | 20.0 | 1 | 0 |
| Standards in genomic sciences | 20.0 | 1 | 0 |
| Peter C. Klatsky | 20.0 | 0 | 1 |
| Charles Limb | 20.0 | 1 | 0 |
| Clinical adaptation of the sperm ubiquiting tag immunoassay (SUTI): relationship of sperm ubiquitylation with sperm quality in gradient-purified semen samples from 93 men from a general infertility clinic population | 20.0 | 0 | 1 |
| The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments | 20.0 | 0 | 1 |
| Health Services Reports | 20.0 | 1 | 0 |
| International Journal of Breast Cancer | 20.0 | 1 | 0 |
| International Journal of Hypertension | 20.0 | 1 | 0 |
| Journal of Interferon Research | 20.0 | 1 | 0 |
| Multidisciplinary Respiratory Medicine | 20.0 | 1 | 0 |
| NCBI Macaca nemestrina Annotation Release 100 | 20.0 | 1 | 0 |
| NCBI Macaca mulatta Annotation Release 102 | 20.0 | 1 | 0 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 20.0 | 0 | 1 |
| Synchronised approach for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| Vasodilators for women undergoing fertility treatment | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| National Violent Death Reporting System | 20.0 | 1 | 0 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility | 20.0 | 0 | 1 |
| Immune therapies for women with history of failed implantation undergoing IVF treatment | 20.0 | 0 | 1 |
| Adherence compounds in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Antibiotics prior to embryo transfer in ART | 20.0 | 0 | 1 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 20.0 | 0 | 1 |
| Synchronised approach for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Soft versus firm catheters for intrauterine insemination | 20.0 | 0 | 1 |
| Conservative treatments in gynaecological cancer for fertility preservation | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Techniques for preparation prior to embryo transfer | 20.0 | 0 | 1 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 20.0 | 0 | 1 |
| Cycle regimens for frozen-thawed embryo transfer | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Semen preparation techniques for intrauterine insemination | 20.0 | 0 | 1 |
| Timing modalities for intrauterine insemination in subfertile couples | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | 20.0 | 0 | 1 |
| Soft versus firm catheters for intrauterine insemination | 20.0 | 0 | 1 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 20.0 | 0 | 1 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted conception | 20.0 | 0 | 1 |
| Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women | 20.0 | 0 | 1 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 20.0 | 0 | 1 |
| Intrauterine insemination versus fallopian tube sperm perfusion for non tubal infertility | 20.0 | 0 | 1 |
| Semen preparation techniques for intrauterine insemination | 20.0 | 0 | 1 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 20.0 | 0 | 1 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| NCBI Nucleotide | 20.0 | 1 | 0 |
| Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples | 20.0 | 0 | 1 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 20.0 | 0 | 1 |
| Dialogues in Clinical Neuroscience | 20.0 | 1 | 0 |
| Sonja A. Rasmussen | 20.0 | 1 | 0 |
| NCBI Protein | 20.0 | 1 | 0 |
| Biochemical basis for the biological clock | 20.0 | 0 | 1 |
| Serum inhibin-B and FSH levels in male polymer production workers | 20.0 | 0 | 1 |
| Biological clock in total darkness: the Clock/MOP3 circadian system of the blind subterranean mole rat | 20.0 | 0 | 1 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 20.0 | 0 | 1 |
| Frozen-thawed embryo transfer cycles: clinical outcomes of single and double blastocyst transfers | 20.0 | 0 | 1 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 20.0 | 0 | 1 |
| Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment | 20.0 | 0 | 1 |
| Relationship of total motile sperm count and percentage motile sperm to successful pregnancy rates following intrauterine insemination | 20.0 | 0 | 1 |
| Monozygotic twins and triplets in association with blastocyst transfer | 20.0 | 0 | 1 |
| Different ovarian stimulation protocols for women with diminished ovarian reserve | 20.0 | 0 | 1 |
| Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial | 20.0 | 0 | 1 |
| Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic | 20.0 | 0 | 1 |
| Infertility, infertility treatment, and congenital malformations: Danish national birth cohort | 20.0 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 20.0 | 0 | 1 |
| Global orchestration of gene expression by the biological clock of cyanobacteria | 20.0 | 0 | 1 |
| Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis | 20.0 | 0 | 1 |
| Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 20.0 | 0 | 1 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 20.0 | 0 | 1 |
| Biological Clock Depends on Many Parts Working Together | 20.0 | 0 | 1 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 20.0 | 0 | 1 |
| Watching the hands of the Arabidopsis biological clock | 20.0 | 0 | 1 |
| Localization and gene expression of steroid sulfatase by RT-PCR in cumulus cells and relationship to serum FSH levels observed during in vitro fertilization | 20.0 | 0 | 1 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 20.0 | 0 | 1 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 20.0 | 0 | 1 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 20.0 | 0 | 1 |
| Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination | 20.0 | 0 | 1 |
| Cryopreservation of testicular tissue or testicular cell suspensions: a pivotal step in fertility preservation | 20.0 | 0 | 1 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 20.0 | 0 | 1 |
| Fertility preservation in women with cervical, endometrial or ovarian cancers | 20.0 | 0 | 1 |
| Poor ovarian reserve | 20.0 | 0 | 1 |
| Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer | 20.0 | 0 | 1 |
| Models Predicting Success of Infertility Treatment: A Systematic Review | 20.0 | 0 | 1 |
| Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET) | 20.0 | 0 | 1 |
| An Update on Ovarian Aging and Ovarian Reserve Tests | 20.0 | 0 | 1 |
| Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers | 20.0 | 0 | 1 |
| Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis | 20.0 | 0 | 1 |
| Fertility treatment in spinal cord injury and other neurologic disease | 20.0 | 0 | 1 |
| Fertility preservation in young patients with cancer | 20.0 | 0 | 1 |
| Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? | 20.0 | 0 | 1 |
| Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women | 20.0 | 0 | 1 |
| Spermatogonial stem cells as a therapeutic alternative for fertility preservation of prepubertal boys | 20.0 | 0 | 1 |
| Fertility preservation for boys and adolescents facing sterilizing medical therapy | 20.0 | 0 | 1 |
| Clinical determinants of mental disorders occurring during the infertility treatment | 20.0 | 0 | 1 |
| Genetics of the ovarian reserve | 20.0 | 0 | 1 |
| Selective Regulation of Oocyte Meiotic Events Enhances Progress in Fertility Preservation Methods | 20.0 | 0 | 1 |
| Chronobiomics: The Biological Clock as a New Principle in Host-Microbial Interactions | 20.0 | 0 | 1 |
| The developmental origins of the mammalian ovarian reserve | 20.0 | 0 | 1 |
| Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? | 20.0 | 0 | 1 |
| Fertility preservation during cancer treatment: clinical guidelines | 20.0 | 0 | 1 |
| The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study | 20.0 | 0 | 1 |
| The prognostic profile of subfertile couples and treatment outcome after expectant management, intrauterine insemination and in vitro fertilisation: a study protocol for the meta-analysis of individual patient data | 20.0 | 0 | 1 |
| Fertility Sparing Surgery in Gynecologic Cancer | 20.0 | 0 | 1 |
| Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice | 20.0 | 0 | 1 |
| Monthly vital statistics report : provisional statistics from the National Center for Health Statistics | 20.0 | 1 | 0 |
| AAPS PharmSci | 20.0 | 1 | 0 |
| Annales de génétique et de sélection animale | 20.0 | 1 | 0 |
| Case Reports in Infectious Diseases | 20.0 | 1 | 0 |
| Psychiatry Journal | 20.0 | 1 | 0 |
| International Journal of Microbiology | 20.0 | 1 | 0 |
| Methodist DeBakey cardiovascular journal | 20.0 | 1 | 0 |
| Case Reports in Neurological Medicine | 20.0 | 1 | 0 |
| Veterinary Medicine International | 20.0 | 1 | 0 |
| European journal of dentistry | 20.0 | 1 | 0 |
| Journal of Osteoporosis | 20.0 | 1 | 0 |
| Current reviews in musculoskeletal medicine | 20.0 | 1 | 0 |
| Case Reports in Surgery | 20.0 | 1 | 0 |
| The Analysis of verbal behavior | 20.0 | 1 | 0 |
| California medicine | 20.0 | 1 | 0 |
| International journal of pediatric endocrinology | 20.0 | 1 | 0 |
| Behavior analysis in practice | 20.0 | 1 | 0 |
| International Journal of Nephrology | 20.0 | 1 | 0 |
| Baylor University Medical Center Proceedings | 20.0 | 1 | 0 |
| Bacteriophage | 20.0 | 1 | 0 |
| Mobile genetic elements | 20.0 | 1 | 0 |
| Annals of Neurosciences | 20.0 | 1 | 0 |
| International Journal of Endocrinology | 20.0 | 1 | 0 |
| International Journal of Dentistry | 20.0 | 1 | 0 |
| Case Reports in Transplantation | 20.0 | 1 | 0 |
| Chimerism | 20.0 | 1 | 0 |
| Medical Hypothesis, Discovery & Innovation ophthalmology journal | 20.0 | 1 | 0 |
| Proceedings - Symposium on Computer Application in Medical Care | 20.0 | 1 | 0 |
| International Journal of Medicinal Chemistry | 20.0 | 1 | 0 |
| International Journal of Cell Biology | 20.0 | 1 | 0 |
| Case Reports in Genetics | 20.0 | 1 | 0 |
| Proceedings. AMIA Annual Symposium | 20.0 | 1 | 0 |
| Journal of Amino Acids | 20.0 | 1 | 0 |
| Innovations in clinical neuroscience | 20.0 | 1 | 0 |
| Cellular logistics | 20.0 | 1 | 0 |
| Advances in Bioinformatics | 20.0 | 1 | 0 |
| Medical history. Supplement | 20.0 | 1 | 0 |
| American health & drug benefits | 20.0 | 1 | 0 |
| Current urology | 20.0 | 1 | 0 |
| Case Reports in Oncological Medicine | 20.0 | 1 | 0 |
| International Journal of Genomics | 20.0 | 1 | 0 |
| Topics in spinal cord injury rehabilitation | 20.0 | 1 | 0 |
| Biomatter | 20.0 | 1 | 0 |
| Comparative and Functional Genomics | 20.0 | 1 | 0 |
| Pulmonary circulation | 20.0 | 1 | 0 |
| Spermatogenesis | 20.0 | 1 | 0 |
| JAK-STAT | 20.0 | 1 | 0 |
| Journal of ocular biology, diseases, and informatics | 20.0 | 1 | 0 |
| Transactions of the American Climatological and Clinical Association | 20.0 | 1 | 0 |
| Journal of Pregnancy | 20.0 | 1 | 0 |
| United European gastroenterology journal | 20.0 | 1 | 0 |
| Genes & Cancer | 20.0 | 1 | 0 |
| Proceedings / AMIA Annual Fall Symposium | 20.0 | 1 | 0 |
| Genitourinary medicine | 20.0 | 1 | 0 |
| Experimental diabesity research | 20.0 | 1 | 0 |
| Medical library and historical journal | 20.0 | 1 | 0 |
| Case Reports in Pathology | 20.0 | 1 | 0 |
| Bioengineered | 20.0 | 1 | 0 |
| Advances in Hematology | 20.0 | 1 | 0 |
| Journal of Lipids | 20.0 | 1 | 0 |
| Nucleus | 20.0 | 1 | 0 |
| Case Reports in Urology | 20.0 | 1 | 0 |
| The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG | 20.0 | 1 | 0 |
| The Journal of psychotherapy practice and research | 20.0 | 1 | 0 |
| Public Health Reports | 20.0 | 1 | 0 |
| Prion | 20.0 | 1 | 0 |
| Science & practice perspectives / a publication of the National Institute on Drug Abuse, National Institutes of Health | 20.0 | 1 | 0 |
| Diagnostic and therapeutic endoscopy | 20.0 | 1 | 0 |
| Self/nonself | 20.0 | 1 | 0 |
| Craniomaxillofacial trauma & reconstruction | 20.0 | 1 | 0 |
| Case Reports in Obstetrics & Gynecology | 20.0 | 1 | 0 |
| The Ochsner journal | 20.0 | 1 | 0 |
| Bacteriological Reviews | 20.0 | 1 | 0 |
| Journal of Ophthalmology | 20.0 | 1 | 0 |
| Advances in Orthopedics | 20.0 | 1 | 0 |
| Kidney International Supplements | 20.0 | 1 | 0 |
| HSMHA Health Reports | 20.0 | 1 | 0 |
| Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation | 20.0 | 0 | 1 |
| Worm | 20.0 | 1 | 0 |
| Rehabilitation Research & Practice | 20.0 | 1 | 0 |
| Reviews in urology | 20.0 | 1 | 0 |
| Hawaiʻi journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health | 20.0 | 1 | 0 |
| The Journal of extra-corporeal technology | 20.0 | 1 | 0 |
| Adipocyte | 20.0 | 1 | 0 |
| International journal of rheumatology | 20.0 | 1 | 0 |
| The primary care companion for CNS disorders | 20.0 | 1 | 0 |
| Case reports in radiology | 20.0 | 1 | 0 |
| International Journal of Hepatology | 20.0 | 1 | 0 |
| Case Reports in Medicine | 20.0 | 1 | 0 |
| British journal of venereal diseases | 20.0 | 1 | 0 |
| Journal of pharmaceutics | 20.0 | 1 | 0 |
| Case Reports in Otolaryngology | 20.0 | 1 | 0 |
| The journal of spinal cord medicine : JSCM | 20.0 | 1 | 0 |
| International Journal of Qualitative Studies on Health and Well-being | 20.0 | 1 | 0 |
| Cardiology Research and Practice | 20.0 | 1 | 0 |
| Global spine journal | 20.0 | 1 | 0 |
| Temperature : multidisciplinary biomedical journal | 20.0 | 1 | 0 |
| Reproduction and Breast Cancer Risk | 20.0 | 0 | 1 |
| Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 20.0 | 0 | 1 |
| Regulation of the ovarian reserve by members of the transforming growth factor beta family | 20.0 | 0 | 1 |
| Strategies for Fertility Preservation in Young Patients with Cancer: A Comprehensive Approach | 20.0 | 0 | 1 |
| Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: A Meta-Analysis | 20.0 | 0 | 1 |
| Fertility preservation in young patients′ with cancer | 20.0 | 0 | 1 |
| The longer-term health outcomes for children born as a result of IVF treatment. Part II-Mental health and development outcomes | 20.0 | 0 | 1 |
| Synchronization of Biological Clock Neurons by Light and Peripheral Feedback Systems Promotes Circadian Rhythms and Health | 20.0 | 0 | 1 |
| The Ovarian Reserve of Primordial Follicles and the Dynamic Reserve of Antral Growing Follicles: What Is the Link?1 | 20.0 | 0 | 1 |
| Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies | 20.0 | 0 | 1 |
| Efficacy of luteal phase support with vaginal progesterone in intrauterine insemination: a systematic review and meta-analysis | 20.0 | 0 | 1 |
| Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis | 20.0 | 0 | 1 |
| Mary Barton | 20.0 | 0 | 1 |